Abstract:Background: Dietary fiber is an integral part of a healthy diet, but questions remain about the mechanisms that underlie effects and the causal contributions of the gut microbiota. Here, we performed a 6-week exploratory trial in adults with excess weight (BMI: 25-35 kg/m2) to compare the effects of a high-dose (females: 25 g/day; males: 35 g/day) supplement of fermentable corn bran arabinoxylan (AX; n = 15) with that of microbiota-non-accessible microcrystalline cellulose (MCC; n = 16). Obesity-related surrogate endpoints and biomarkers of host-microbiome interactions implicated in the pathophysiology of obesity (trimethylamine N-oxide, gut hormones, cytokines, and measures of intestinal barrier integrity) were assessed. We then determined whether clinical outcomes could be predicted by fecal microbiota features or mechanistic biomarkers. Results: AX enhanced satiety after a meal and decreased homeostatic model assessment of insulin resistance (HOMA-IR), while MCC reduced tumor necrosis factor-α and fecal calprotectin. Machine learning models determined that effects on satiety could be predicted by fecal bacterial taxa that utilized AX, as identified by bioorthogonal non-canonical amino acid tagging. Reductions in HOMA-IR and calprotectin were associated with shifts in fecal bile acids, but correlations were negative, suggesting that the benefits of fiber may not be mediated by their effects on bile acid pools. Biomarkers of host-microbiome interactions often linked to bacterial metabolites derived from fiber fermentation (short-chain fatty acids) were not affected by AX supplementation when compared to non-accessible MCC. Conclusion: This study demonstrates the efficacy of purified dietary fibers when used as supplements and suggests that satietogenic effects of AX may be linked to bacterial taxa that ferment the fiber or utilize breakdown products. Other effects are likely microbiome independent. The findings provide a basis for fiber-type specific therapeutic applications and their personalization. Trial registration: Clinicaltrials.gov, NCT02322112 , registered on July 3, 2015. Video Abstract.

In-depth insight into correlations between gut microbiota and dietary fiber elucidates a dietary causal relationship with host health

Dietary Fiber and Its Potential Role in Obesity: A Focus on Modulating the Gut Microbiota

Gut microbiota determines the fate of dietary fiber-targeted interventions in host health

The Gut Microbiome: Linking Dietary Fiber to Inflammatory Diseases

Dietary Fiber Intake and Gut Microbiota in Human Health

Gut firmicutes: Relationship with dietary fiber and role in host homeostasis

A Critical Review on Interplay Between Dietary Fibers and Gut Microbiota

Contribution of Diet to Gut Microbiota and Related Host Cardiometabolic Health: Diet-Gut Interaction in Human Health.

Effects of Diet on Gut Microbiota Profile and the Implications for Health and Disease

Dietary Fiber and Polyphenols from Whole Grains: Effects on Gut and Health Improvement

Gut microbiome variation modulates the effects of dietary fiber on host metabolism

Dietary fiber and polyphenols from whole grains: effects on the gut and health improvements

Journey of dietary fiber along the gastrointestinal tract: role of physical interactions, mucus, and biochemical transformations

Dietary Nutrition and Gut Microflora: A Promising Target for Treating Diseases

Let food be your medicine - dietary fiber

Elucidating the role of the gut microbiota in the physiological effects of dietary fiber

Gut Microbiome: Profound Implications for Diet and Disease

A review of healthy role of dietary fiber in modulating chronic diseases

The Effects of Food Nutrients and Bioactive Compounds on the Gut Microbiota: A Comprehensive Review

The gut microbiome and dietary fibres: implications in obesity, cardiometabolic diseases and cancer

Targeted Modification of Gut Microbiota and Related Metabolites Via Dietary Fiber